Latest filing published 29 Apr 2026 for Schwab Charles CORP, €195k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -4.7%Entry US$150.01 · Close at T+365 US$143.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frank C. Herringer: trading record in brief
Frank C. Herringer sits as a Director of Schwab Charles Corp (36 filings) and Amgen Inc (6), for 42 filings published from March 16, 2016 to April 29, 2026.
Four open-market sales, all at Schwab, total EUR 1,552,445, median EUR 334,420: EUR 688,762 on February 14, 2023, EUR 437,148 on February 1, 2024 and EUR 231,692 on April 21, 2025. No purchase. The rest of the record: 22 grants, 12 option exercises and 4 other lines.
The yearly curve declines: 8 filings in 2016, 6 in 2019 and 5 in 2023, then 3 a year in 2024 and 2025 and 1 in 2021 at the low. Two filings fall in the last twelve months, one of them a sale. Median publication delay: 2 days. Charles R. Schwab has 4 trades within 30 days of trades by Frank C. Herringer, in the same direction; Carolyn Schwab-Pomerantz, Charles A. Ruffel, Jonathan M. Craig and Nigel J. Murtagh have 2 each.
Companies and markets linked to Frank C. Herringer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,520 shares@ US$90.60060.0001% mcap14.9% of flowCommon StockSEC:0001171694-26-000006:1
- 7,866 shares@ US$28.960.0001% mcap14.9% of flowCommon StockSEC:0001171694-26-000006:0
- 1,462 shares0Common StockSEC:0001171694-25-000008:0
- 3,592 shares@ US$74.265.1% of flowCommon StockSEC:0001171694-25-000006:1
- 8,548 shares@ US$31.2117.8% of flowCommon StockSEC:0001171694-25-000006:0
- 1,809 shares0Common StockSEC:0001171694-24-000009:0
- 7,587 shares@ US$62.259.7% of flowCommon StockSEC:0001171694-24-000004:1
- 10,511 shares@ US$25.0118.7% of flowCommon StockSEC:0001171694-24-000004:0
- 2,496 shares0Common StockSEC:0001062993-23-012112:0
- 9,139 shares@ US$80.8715.3% of flowCommon StockSEC:0001062993-23-003859:3
- 14,345 shares0Common StockSEC:0001062993-23-003859:1
- 14,345 shares0Common StockSEC:0001062993-23-003859:2
- 14,345 shares@ US$19.2119.7% of flowCommon StockSEC:0001062993-23-003859:0
- 2,054 shares0Common StockSEC:0001225208-22-007290:0
- 2,209 shares@ US$94.484.1% of flowCommon StockSEC:0001225208-22-001804:1
- 16,491 shares@ US$12.6614.0% of flowCommon StockSEC:0001225208-22-001804:0
- 1,529 shares0Common StockSEC:0001225208-21-008334:0
- 11,344 shares@ US$17.6210.3% of flowCommon StockSEC:0001225208-20-013511:0
- 4,281 shares@ US$46.68510.3% of flowCommon StockSEC:0001225208-20-013511:1
- 3,396 shares0Common StockSEC:0001225208-20-007925:0
- 11,082 shares@ US$17.387.7% of flowCommon StockSEC:0001225208-19-015027:0
- 3,912 shares@ US$49.237.7% of flowCommon StockSEC:0001225208-19-015027:1
- 1,841 shares0Common StockSEC:0001225208-19-008341:0
- 1,127 shares0Common StockSEC:0001127602-19-017640:0
- 8,356 shares@ US$18.005.2% of flowCommon StockSEC:0001225208-19-003900:0
25 of 107 declarations
